- Home
- » Tags
- » Amodiaquine
Top View
- Malaria Chemotherapy & Drug Resistance
- Manufacturing Generic Drugs
- Flockhart Table – Medication Metabolism
- Medicines Amendment Regulations 2018
- Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……
- Vasodilator for Use to Treat Microbial Infections
- CHMP Agenda of the 17-20 July 2017 Meeting
- Novel Modulation of Adenylyl Cyclase Type 2 Jason Michael Conley Purdue University
- Guidelines-10.1 30032021 1.Pdf
- The Antimalarial Drug Amodiaquine Stabilizes P53 Through Ribosome Biogenesis Stress, Independently of Its Autophagy-Inhibitory Activity
- Diagnosis and Management of Idiopathic Drug-Induced and Severe
- Structural Basis for Inhibition of Histamine N
- June-06 Inventory of Projects Progress Report: Implementation Of
- Product List
- In Vitro Assessment of the Pharmacokinetic Drug
- Elzbieta Chalecka-Franaszek, Ph.D. NDA No. 22-117
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Investigating the Mechanism of Action of Artemisinin Antimalarials and the Role of Ferriprotoporphyrin Ix Heme
- The Cardiotoxicity of Antimalarials
- Part 4 October 2017 Hydrochloride 150Mg/75Mg/400Mg/275Mg Film-Coated Section 7 Updated: April 2020 Tablets, (Micro Labs Limited), TB 223
- Guidelines for Case Management of Malaria.FINAL.Cdr
- Aldehyde Oxidase and Its Role As a Drug Metabolizing Enzyme
- Gauging Reactive Metabolites in Drug-Induced Toxicity
- ARTESUNATE AMODIAQUINE WINTHROP 25 Mg/67.5 Mg, Tablet ARTESUNATE AMODIAQUINE WINTHROP 50 Mg/135 Mg, Tablet ARTESUNATE AMODIAQUINE WINTHROP 100 Mg/270 Mg, Tablet
- FIXED DOSE COMBINATIONS APPROVED by DCG (I) SINCE 1961 TILL 20Th December 2018
- Download (Accessed on 20 July 2019)
- Guidelines for the Treatment of Malaria
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Compounds Chloroquine, and Structurally Related Cpg
- Inhibitors of Topoisomerase II As Ph-Dependent Modulators of Etoposide-Mediated Cytotoxicity1
- Antimalarial Drug Discovery Using Triazoles to Overcome Chloroquine Resistance
- Evaluation of Clinical Drug Interaction Potential of Clofazimine Using Static and Dynamic Modeling Approaches
- Repurposing Non-Cancer Drugs in Oncology – How Many Drugs Are out There?
- In Vivo Activity of Amodiaquine Against Ebola Virus Infection Lisa Evans Dewald1,2, Joshua C
- Reactive Metabolites/Covalent Binding
- A Controlled Trial to Assess the Effect of Quinine, Chloroquine, Amodiaquine, and Artesunate on Loa Loa Microfilaremia
- Targeting Quorum Sensing
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Supplementary Table 1: List of Drugs and Their Binding Energies to ACE and ACE2
- WO 2017/053594 Al 30 March 2017 (30.03.2017) P O P C T
- Rank Cmap Name 1 Trichostatin a 2 Piribedil 3 Omeprazole 4 MS-275 5 Penbutolol 6 Calcium Folinate 7 Phthalylsulfathiazole 8 Clop
- The Selection and Use of Essential Medicines
- List Item Minutes of the CHMP Meeting 17-20 July 2017
- WHO Drug Information Vol. 20, No. 1, 2006
- STUDY PROTOCOL Sponsor’S Reference Number: APM/18/1702001 Richmond Pharmacology Study Number: C18034 Eudract Number: 2018-004968-60
- Global Health Challenges Drug Delivery Innovations to Address
- A Randomized Comparison of Dihydroartemisinin-Piperaquine
- 18-12-2017 WHO Model List of Essential Medicines for Children
- Pediatric Movement Disorders
- 3Hp Drug-Drug Interactions, Including Art
- Blood Schizontocidal Activity of Methylene Blue in Combination with Antimalarials Againstplasmodium Falciparum
- 1399.Full.Pdf
- Absence of Association Between Methylene Blue Reduced
- Antimicrobial Resistance Benchmark 2018 METHODOLOGY 2017 Methodology for the 2018 Antimicrobial Resistance Benchmark
- Cheminformatic and Mechanistic Study of Drug Subcellular Transport/Distribution
- CHAPTER E26 Pharmacology of Agents Used to Treat Parasitic Infections
- Development of Quantitative HPTLC-Densitometry Methods